Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
The company has been in a very positive evolution with new CEO and mix of new and existing leadership team. Clear commitment to strong and positive culture, people, patients and results.
Qual é a melhor parte das suas compensações?
Fair evaluation of goals and receipt of bonus
O que faz você mais feliz no trabalho?
trial results that focus on patients
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
actively being evolved with clear commitment to people, teams and patients
O que você mais gosta nos lideres?
Actively evolved from past control and command to engaged, aligned and capable team!!
Quais são algumas das melhores coisas da sua equipe?
Increasingly aligned and capable with a strong commitment to work together and lack of politics
Other Employee Reviews for Karyopharm Therapeutics
×